Skandinaviska Enskilda Banken (SEB)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Hold |
59,978
| – | – | 0.04% | 330 |
|
|
2025
Q1 | $10.8M | Sell |
59,978
-29,069
| -33% | -$5.24M | 0.05% | 265 |
|
|
2024
Q4 | $14.2M | Sell |
89,047
-37,035
| -29% | -$5.92M | 0.06% | 220 |
|
|
2024
Q3 | $23M | Sell |
126,082
-65,433
| -34% | -$11.9M | 0.11% | 162 |
|
|
2024
Q2 | $35.2M | Sell |
191,515
-26,232
| -12% | -$4.82M | 0.17% | 105 |
|
|
2024
Q1 | $38.7M | Sell |
217,747
-26,314
| -11% | -$4.68M | 0.19% | 96 |
|
|
2023
Q4 | $30.3M | Hold |
244,061
| – | – | 0.18% | 115 |
|
|
2023
Q3 | $28.3M | Sell |
244,061
-41,799
| -15% | -$4.85M | 0.19% | 104 |
|
|
2023
Q2 | $33.6M | Sell |
285,860
-158
| -0.1% | -$18.5K | 0.22% | 98 |
|
|
2023
Q1 | $22.9M | Sell |
286,018
-1,523
| -0.5% | -$122K | 0.16% | 138 |
|
|
2022
Q4 | $22.8M | Sell |
287,541
-10,069
| -3% | -$798K | 0.17% | 140 |
|
|
2022
Q3 | $20.7M | Hold |
297,610
| – | – | 0.16% | 128 |
|
|
2022
Q2 | $19.5M | Buy |
297,610
+88,899
| +43% | +$5.84M | 0.14% | 148 |
|
|
2022
Q1 | $13.9M | Sell |
208,711
-115
| -0.1% | -$7.65K | 0.08% | 218 |
|
|
2021
Q4 | $14.7M | Buy |
208,826
+75,825
| +57% | +$5.35M | 0.08% | 228 |
|
|
2021
Q3 | $6.94M | Buy |
133,001
+6,709
| +5% | +$350K | 0.04% | 352 |
|
|
2021
Q2 | $8.59M | Buy |
126,292
+112,671
| +827% | +$7.66M | 0.05% | 311 |
|
|
2021
Q1 | $1.05M | Buy |
+13,621
| New | +$1.05M | 0.01% | 817 |
|